Back

Beta-blockers in diabetes with stable coronary heart disease- a cause for concern?

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Diabetes and the heart Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Assistant Professor Aaqib H Malik

Catholic Medical Center, Manchester (United States of America)

6 More presentations in this session

Presentation thumbnail
Peripheral neuropathy and diastolic function are associated with adverse cardiovascular outcome in patients with type 1 diabetes mellitus: results from the thousand & 1 study
Doctor M. Jensen (Herlev, DK)
Abstract
Presentation thumbnail
Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes: data from the Look AHEAD trial.
Miss T. de Vries (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment
Doctor I. Ikonomidis (Athens, GR)
Abstract
Presentation thumbnail
The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetes
Doctor A. Mader (Feldkirch, AT)
Abstract Slides
Presentation thumbnail
Tissue sodium concentration emerged as a determinant of hypertrophic vascular remodeling in type 2 diabetes
Miss S. Jung (Erlangen, DE)
Abstract Slides

Access the full session

Session thumbnail
Diabetes and the heart

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting
thumbnail
Congress Presentation
Cardiovascular risk reduction: should we target pre-diabetes?
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources